Learning, memory, and cognition are thought to require normal long-term potentiation (LTP) of synaptic strength, which in turn requires binding of the Ca 2؉ /calmodulin-dependent protein kinase II (CaMKII) to the NMDA-type glutamate receptor (NMDAR) subunit GluN2B. For LTP induction, many additional required players are known. Here we tested the hypothesis that CaMKII/GluN2B binding also mediates the more elusive maintenance of synaptic strength. Intriguingly, the CaMKII inhibitor tatCN21 reduces synaptic strength only at high concentrations necessary for CaMKII/NMDAR disruption (20 M) but not at lower concentrations sufficient for kinase inhibition (5 M). However, increased concentration also causes unrelated effects. Thus, to distinguish between correlation and causality, we used a pharmacogenetic approach. In a mouse with a mutant NMDAR GluN2B subunit that is CaMKII binding-incompetent, any tatCN21 effects that are specific to the CaMKII/GluN2B interaction should be abolished, and any remaining tatCN21 effects have to be nonspecific (i.e. mediated by other targets). The results showed that the persistent reduction of synaptic strength by transient application of 20 M tatCN21 had a nonspecific presynaptic component (on fiber volley amplitude) that was unrelated to the CaMKII/GluN2B interaction or CaMKII activity. However, the remaining component of the persistent tatCN21 effect was almost completely abolished in the GluN2B mutant mouse. These results highlight the requirement for stringent pharmacogenetic approaches to separate specific ontarget effects from nonspecific off-target effects. Importantly, they also demonstrate that the CaMKII/GluN2B interaction is required not only for normal LTP induction but also for the maintenance of synaptic strength.The Ca 2ϩ /calmodulin-dependent protein kinase II (CaM-KII) 3 and the NMDA-type glutamate receptor (NMDAR) are central mediators of long-term potentiation (LTP) and depression (LTD), forms of synaptic plasticity thought to underlie learning, memory, and cognition (1; for a review, see Refs. 2-5). Many additional molecular players have been implicated in the induction of these changes of synaptic strength (4, 6, 7); however, the mechanisms responsible for then maintaining synaptic strength have been elusive. CaMKII has been hypothesized to mediate not only LTP induction but also the maintenance of synaptic strength (2-4), as Ca 2ϩ influx through NMDARs triggers CaMKII autophosphorylation at Thr-286 to generate Ca 2ϩ -independent "autonomous" kinase activity, a process that can provide "molecular memory" of the initial Ca 2ϩ stimulus (8, 9). However, although CaMKII Thr-286 phosphorylation is indeed required for LTP (10), this requirement is for induction rather than maintenance. Thr-286 phosphorylation of synaptic CaMKII is reversed within 2 min of LTP induction (11), and CaMKII inhibition after LTP induction does not affect maintenance (9). Another kinase that has received prominent attention as a "memory kinase" is PKM, and its inhibitor myrZIP does indeed reve...